Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04969861
Title BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nektar Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | AUT

Facility Status City State Zip Country Details
Nebraska Methodist Hospital Omaha Nebraska 68114 United States Details
Universitätsklinikum Salzburg, Landeskrankenhaus, Salzburg Salzburg Bundesland 5020 Austria Details
Attikon University General Hospital Athens Attiki Greece Details
ASST Degli Spedali Civili di Brescia Brescia Lombardia Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field